What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex.
Enter Immunai, a biotechnology company that’s using AI technology to map the human immune system and speed the development of new imm ... Show More
Mar 4
Powering the AI Inference Wave with EPRI's Ben Sooter - Ep. 292
AI is reshaping electricity demand. What does increased demand, and the shape of that demand, mean for the electric grid? Ben Sooter, Director of R&D at EPRI joins the podcast to explain why most of an AI model’s lifetime energy use comes from inference rather than training, and ... Show More
32m 20s
Feb 27
AI Agents and the Future of Global Trade with Alibaba’s Kuo Zhang - Ep. 291
Alibaba.com president Kuo Zhang discusses how AI agents like Accio are reshaping global trade. He shares insights on automating complex B2B sourcing, compressing weeks of work into minutes, lowering barriers for solo entrepreneurs and SMEs, and what AI-native commerce will mean f ... Show More
33m 13s
May 2024
Grant Mitchell — The Potential of AI Drug Repurposing
<p>Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing.</p> <p>Grant joins the sho ... Show More
1h 5m
<p>Immune explains how mast cells, IgE antibody, and the brain collaborate to promote avoidance of certain foods to evade allergic responses.</p> <p>Hosts: <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello" target="_blank" rel="noreferrer noopener">Vincent Racaniello</a>, ... Show More
